Whistle-blower claim that Lipitor marketing violated guidelines rejected

U.S. district judge Brian Cogan dismissed with prejudice a former Pfizer employee's claim that the company illegally promoted the cholesterol drug Lipitor for off-label uses.

This article requires free registration

This article requires free registration to Daily Business Review. Please sign in or register to read the full text.